U.S. flag

An official website of the United States government

NM_001018005.2(TPM1):c.14AGA[4] (p.Lys7dup) AND not specified

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Apr 29, 2016
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000601316.4

Allele description [Variation Report for NM_001018005.2(TPM1):c.14AGA[4] (p.Lys7dup)]

NM_001018005.2(TPM1):c.14AGA[4] (p.Lys7dup)

Gene:
TPM1:tropomyosin 1 [Gene - OMIM - HGNC]
Variant type:
Microsatellite
Cytogenetic location:
15q22.2
Genomic location:
Preferred name:
NM_001018005.2(TPM1):c.14AGA[4] (p.Lys7dup)
Other names:
p.Lys7_Met8insLys
HGVS:
  • NC_000015.10:g.63042843AGA[4]
  • NG_007557.1:g.5205AGA[4]
  • NM_000366.6:c.14AGA[4]
  • NM_001018004.2:c.14AGA[4]
  • NM_001018005.2:c.14AGA[4]MANE SELECT
  • NM_001018006.2:c.14AGA[4]
  • NM_001018007.2:c.14AGA[4]
  • NM_001018020.2:c.14AGA[4]
  • NM_001301244.2:c.14AGA[4]
  • NM_001365776.1:c.14AGA[4]
  • NM_001365777.1:c.14AGA[4]
  • NM_001365778.1:c.14AGA[4]
  • NM_001365779.1:c.14AGA[4]
  • NP_000357.3:p.Lys7dup
  • NP_001018004.1:p.Lys7dup
  • NP_001018005.1:p.Lys7dup
  • NP_001018006.1:p.Lys7dup
  • NP_001018007.1:p.Lys7dup
  • NP_001018020.1:p.Lys7dup
  • NP_001288173.1:p.Lys7dup
  • NP_001352705.1:p.Lys7dup
  • NP_001352706.1:p.Lys7dup
  • NP_001352707.1:p.Lys7dup
  • NP_001352708.1:p.Lys7dup
  • LRG_387t1:c.14AGA[4]
  • LRG_387:g.5205AGA[4]
  • LRG_387p1:p.Lys7dup
  • NC_000015.9:g.63335042AGA[4]
  • NC_000015.9:g.63335050_63335051insAGA
Links:
dbSNP: rs730881155
NCBI 1000 Genomes Browser:
rs730881155
Molecular consequence:
  • NM_000366.6:c.14AGA[4] - inframe_insertion - [Sequence Ontology: SO:0001821]
  • NM_001018004.2:c.14AGA[4] - inframe_insertion - [Sequence Ontology: SO:0001821]
  • NM_001018005.2:c.14AGA[4] - inframe_insertion - [Sequence Ontology: SO:0001821]
  • NM_001018006.2:c.14AGA[4] - inframe_insertion - [Sequence Ontology: SO:0001821]
  • NM_001018007.2:c.14AGA[4] - inframe_insertion - [Sequence Ontology: SO:0001821]
  • NM_001018020.2:c.14AGA[4] - inframe_insertion - [Sequence Ontology: SO:0001821]
  • NM_001301244.2:c.14AGA[4] - inframe_insertion - [Sequence Ontology: SO:0001821]
  • NM_001365776.1:c.14AGA[4] - inframe_insertion - [Sequence Ontology: SO:0001821]
  • NM_001365777.1:c.14AGA[4] - inframe_insertion - [Sequence Ontology: SO:0001821]
  • NM_001365778.1:c.14AGA[4] - inframe_insertion - [Sequence Ontology: SO:0001821]
  • NM_001365779.1:c.14AGA[4] - inframe_insertion - [Sequence Ontology: SO:0001821]
Observations:
1

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000712021Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
criteria provided, single submitter

(LMM Criteria)
Uncertain significance
(Apr 29, 2016)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot provided11not providednot providednot providedclinical testing

Citations

PubMed

A systematic approach to assessing the clinical significance of genetic variants.

Duzkale H, Shen J, McLaughlin H, Alfares A, Kelly MA, Pugh TJ, Funke BH, Rehm HL, Lebo MS.

Clin Genet. 2013 Nov;84(5):453-63. doi: 10.1111/cge.12257.

PubMed [citation]
PMID:
24033266
PMCID:
PMC3995020

Details of each submission

From Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine, SCV000712021.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (1)

Description

The p.Lys5[4] variant in TPM1 has not been previously reported in individuals wi th cardiomyopathy or in large population studies, though the ability of these st udies to accurately detect indels may be limited. This variant is a duplication of a lysine (Lys) in a repeat region and is not predicted to alter the protein r eading frame. It is unclear if this duplication will impact the protein. In summ ary, the clinical significance of the p.Lys5[4] variant is uncertain.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot provided1not provided1not provided

Last Updated: Dec 24, 2022